Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy - A retrospective analysis

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Piroth, Marc D ^a   Pinkawa, Michael ^a   Gagel, Bernd ^a   Stanzel, Sven ^a   Asadpour, Branka ^a   Eble, Michael J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PROTEIN LOCALIZATION; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THORAX WALL; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL PROTOCOL; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 43649102762     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-114     Document Type: Article

References (39)

1. Bellon JR Come SE Gelman RS Henderson IC Shulman LN Silver BJ Harris JR Recht A Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial Journal of Clinical Oncology 2005, 23:1934-1940. 10.1200/JCO.2005.04.032 15774786
2. Recht A Come SE Henderson IC Gelman RS Silver B Hayes DF Shulman LN Harris JR The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer N Engl J Med 1996, 334:1356-1361. 10.1056/NEJM199605233342102 8614420
3. Bellon JR Harris JR Chemotherapy and radiation therapy for breast cancer: What is the optimal sequence?[comment] Journal of Clinical Oncology 2005, 23:5-7. 10.1200/JCO.2005.09.962 15545662
4. Buchholz TA Austin-Seymour MM Moe RE Ellis GK Livingston RB Pelton JG Griffin TW Effect of delay in radiation in the combined modality treatment of breast cancer Int J Radiat Oncol Biol Phys 1993, 26:23-35. 8482628
5. Hartsell WF Recine DC Griem KL Murthy AK Hartsell WF Recine DC Griem KL Murthy AK Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence Cancer 1995, 76:2497-2503. 10.1002/ 1097-0142(19951215)76:12<2497::AID-CNCR2820761214>3.0.CO;2-6 8625076
6. Recht A Come SE Gelman RS Goldstein M Tishler S Gore SM Abner AL Vicini FA Silver B Connolly JL Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: Sequencing, timing, and outcome J Clin Oncol 1991, 9:1662-1667. 1875223
7. Buchholz TA Hunt KK Amosson CM Tucker SL Strom EA McNeese MD Buzdar AU Singletary SE Hortobagyi GN Sequencing of chemotherapy and radiation in lymph node-negative breast cancer Cancer J Sci Am 1999, 5:159-164. 10367172
8. Leonard CE Wood ME Zhen B Rankin J Waitz DA Norton L Howell K Sedlacek S Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol 1995, 13:2906-2915. 8523054
9. Vujovic O Perera F Dar AR Stitt L Yu E Voruganti SM Truong PT Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys 1998, 40:869-874. 10.1016/ S0360-3016(97)00922-X 9531372
10. Buzdar AU Kau SW Smith TL Ames F Singletary E Strom E McNeese M Hortobagyi GN The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer Cancer 1993, 71:3680-3684. 10.1002/ 1097-0142(19930601)71:11<3680::AID-CNCR2820711134gt;3.0.CO;2-O 8490917
11. Goldhirsch A Glick JH Gelber RD Coates AS Thurlimann B Senn HJ Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 2005, 16:1569-1583. 10.1093/annonc/ mdi326 16148022
12. Abrams JS Adjuvant therapy for breast cancer--results from the USA consensus conference Breast Cancer 2001, 8:298-304. 11791121
13. Eifel P Axelson JA Costa J Crowley J Curran WJ Deshler A Fulton S Hendricks CB Kemeny M Kornblith AB Louis TA Markman M Mayer R Roter D National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000 Journal of the National Cancer Institute 2001, 93:979-989. 10.1093/jnci/ 93.13.979 11438563
14. Abe O Abe R Enomoto K Kikuchi K Koyama H Nomura Y Sakai K Sugimachi K Tominaga T Uchino J Yoshida M Benraadt J van de Velde AO van Dongen JA Vermorken JB Giokas G Lissaios B Harvey VJ Holdaway TM Kay RG Mason BH Coates A Forbes JF Focan C Lobelle JP Gates GD Powell J Durand M Mauriac L Bartholomeus S Piccart MJ Gelman RS Henderson IC Shapiro CL Hancock AK Masood MB Parker D Price JJ Jackson S Ragaz J Delozier T Mace-Lesec'h J Haybittle JL Berry D Broadwater G Cirrincione C Muss H Norton L Baum M Houghton J Riley D Dent DM Gudgeon CA Hacking A Gordon NH Davis HL Romestaing P Lehingue Y Owen JR Meier P Howell A Ribeiro GC Swindell R Albano J de Oliveira CF Gervasio H Gordilho J Carstensen B Palshof T Johansen H Korzeniowski S Skolyszewski J Portnoj SM Andersen KW Axelsson CK Blichert-Toft M Mouridsen HT Overgaard M Rose C Corcoran N Trampisch HJ Comis RL Davidson NE Gray R Robert N Tormey DC Wood W Chetty U Forrest P Jack W Rossbach J Sylvester RJ van de Velde CJH Cunningham MP Bonneterre J Fumoleau P Namer M Bastert G Rauschecker H et al. Polychemotherapy for early breast cancer: An overview of the randomised trials Lancet 1998, 352:930-942. 10.1016/ S0140-6736(98)03301-7 9752815
15. Levine MN Bramwell VH Pritchard KI Norris BD Shepherd LE bu-Zahra H Findlay B Warr D Bowman D Myles J Arnold A Vandenberg T MacKenzie R Robert J Ottaway J Burnell M Williams CK Tu DS Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer Journal of Clinical Oncology 1998, 16:2651-2658. 9704715
16. Kurtz J The curative role of radiotherapy in the treatment of operable breast cancer Eur J Cancer 2002, 38:1961-1974. 10.1016/ S0959-8049(02)00314-3 12376199
17. Harbeck N Adjuvant chemotherapy in primary breast cancer Onkologie 2003, 26:17-20. 10.1159/000076169 14716137
18. Gilcrease MZ Sahin A Pathological evaluation of axillary sentinel lymph nodes in breast cancer Methods Mol Med 2006, 120:113-125. 16491598
19. Kim KJ Huh SJ Yang JH Park W Nam SJ Kim JH Lee JH Kang SS Lee JE Kang MK Park YJ Nam HR Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy Jpn J Clin Oncol 2005, 35:126-133. 10.1093/jjco/hyi039 15741302
20. Sivridis E Giatromanolaki A Galazios G Koukourakis MI Node-related factors and survival in node-positive breast carcinomas Breast 2006, 15:382-389. 10.1016/j.breast.2005.06.010 16135406
21. Yildirim E Berberoglu U Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients World J Surg 2007, 31:276-289. 10.1007/s00268-006-0487-5 17219275
22. Huang EH Tucker SL Strom EA McNeese MD Kuerer HM Hortobagyi GN Buzdar AU Valero V Perkins GH Schechter NR Hunt KK Sahin AA Buchholz TA Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy Int J Radiat Oncol Biol Phys 2005, 62:351-357. 15890574
23. Katz A Strom EA Buchholz TA Theriault R Singletary SE McNeese MD The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy Int J Radiat Oncol Biol Phys 2001, 50:735-742. 10.1016/S0360-3016(01)01465-1 11395242
24. Gruber G Bonetti M Nasi ML Price KN Castiglione-Gertsch M Rudenstam CM Holmberg SB Lindtner J Golouh R Collins J Crivellari D Carbone A Thurlimann B Simoncini E Fey MF Gelber RD Coates AS Goldhirsch A Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: Long-term observations from International Breast Cancer Study Group Trial VI J Clin Oncol 2005, 23:7089-7097. 10.1200/JCO.2005.08.123 16192592
25. Nielsen HM Overgaard M Grau C Jensen AR Overgaard J Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials Radiother Oncol 2006, 79:147-155. 10.1016/ j.radonc.2006.04.006 16647152
26. Stranzl H Ofner P Peintinger F Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control? Strahlenther Onkol 2006, 182:583-588. 10.1007/ s00066-006-1562-4 17013571
27. Overgaard M Hansen PS Overgaard J Rose C Andersson M Bach F Kjaer M Gadeberg CC Mouridsen HT Jensen MB Zedeler K Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 1997, 337:949-955. 10.1056/NEJM199710023371401 9395428
28. Ragaz J Olivotto IA Spinelli JJ Phillips N Jackson SM Wilson KS Knowling MA Coppin CM Weir L Gelmon K Le N Durand R Coldman AJ Manji M Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 2005, 97:116-126. 15657341
29. Markiewicz DA Schultz DJ Haas JA Harris EE Fox KR Glick JH Solin LJ The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy International Journal of Radiation Oncology, Biology, Physics 1996, 35:661-668. 8690631
30. Bellon JR Shulman LN Come SE Li X Gelman RS Silver BJ Harris JR Recht A Bellon JR Shulman LN Come SE Li X Gelman RS Silver BJ Harris JR Recht A A prospective study of concurrent cyclophosphamide/methotrexate/ 5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma Cancer 2004, 100:1358-1364. 10.1002/ cncr.20136 15042668
31. Fiets WE van Helvoirt RP Nortier JW van T I Struikmans H Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study Eur J Cancer 2003, 39:1081-1088. 10.1016/S0959-8049(03)00178-3 12736107
32. Goldhirsch A Wood W Gelber R Coates A Thurlimann B Senn HJ Members P Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 2007, 18:1133-1144. 10.1093/annonc/mdm271 17675394
33. Greco FA Brereton HD Kent H Zimbler H Merrill J Johnson RE Adriamycin and enhanced radiation reaction in normal esophagus and skin Ann Intern Med 1976, 85:294-298. 183577
34. Vegesna V Withers HR McBride WH Holly FE Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse Int J Radiat Oncol Biol Phys 1992, 23:977-981. 1386355
35. Taghian AG Assaad SI Niemierko A Kuter I Younger J Schoenthaler R Roche M Powell SN Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel J Natl Cancer Inst 2001, 93:1806-1811. 10.1093/jnci/93.23.1806 11734597
36. Taghian AG Assaad SI Niemierko A Floyd SR Powell SN Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys 2005, 62:386-391. 15890579
37. Hickey BE Francis D Lehman MH Sequencing of chemotherapy and radiation therapy for early breast cancer Cochrane Database Syst Rev 2006 CD005212 17054248
38. [Radiotherapy of breast carcinoma. 2005 version] Strahlenther Onkol 2006, 182:4-28. 16613299
39. Recht A Edge SB Solin LJ Robinson DS Estabrook A Fine RE Fleming GF Formenti S Hudis C Kirshner JJ Krause DA Kuske RR Langer AS Sledge GW Jr. Whelan TJ Pfister DG Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 2001, 19:1539-1569. 11230499